ICD-10-CM › T

ICD-10-CM codes starting with T

14,751 codes, page 70 of 148. Every code ever valid for billing is listed, including those now retired.

CodeDescriptionStatus
T44.2X1S Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela Valid
T44.2X2 Poisoning by ganglionic blocking drugs, intentional self-harm Not billable
T44.2X2A Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter Valid
T44.2X2D Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter Valid
T44.2X2S Poisoning by ganglionic blocking drugs, intentional self-harm, sequela Valid
T44.2X3 Poisoning by ganglionic blocking drugs, assault Not billable
T44.2X3A Poisoning by ganglionic blocking drugs, assault, initial encounter Valid
T44.2X3D Poisoning by ganglionic blocking drugs, assault, subsequent encounter Valid
T44.2X3S Poisoning by ganglionic blocking drugs, assault, sequela Valid
T44.2X4 Poisoning by ganglionic blocking drugs, undetermined Not billable
T44.2X4A Poisoning by ganglionic blocking drugs, undetermined, initial encounter Valid
T44.2X4D Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter Valid
T44.2X4S Poisoning by ganglionic blocking drugs, undetermined, sequela Valid
T44.2X5 Adverse effect of ganglionic blocking drugs Not billable
T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter Valid
T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter Valid
T44.2X5S Adverse effect of ganglionic blocking drugs, sequela Valid
T44.2X6 Underdosing of ganglionic blocking drugs Not billable
T44.2X6A Underdosing of ganglionic blocking drugs, initial encounter Valid
T44.2X6D Underdosing of ganglionic blocking drugs, subsequent encounter Valid
T44.2X6S Underdosing of ganglionic blocking drugs, sequela Valid
T44.3 Poisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics Not billable
T44.3X Poisoning by, adverse effect of and underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics Not billable
T44.3X1 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional) Not billable
T44.3X1A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter Valid
T44.3X1D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter Valid
T44.3X1S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela Valid
T44.3X2 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm Not billable
T44.3X2A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter Valid
T44.3X2D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter Valid
T44.3X2S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela Valid
T44.3X3 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault Not billable
T44.3X3A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter Valid
T44.3X3D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter Valid
T44.3X3S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela Valid
T44.3X4 Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined Not billable
T44.3X4A Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter Valid
T44.3X4D Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter Valid
T44.3X4S Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela Valid
T44.3X5 Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics Not billable
T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter Valid
T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter Valid
T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela Valid
T44.3X6 Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics Not billable
T44.3X6A Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter Valid
T44.3X6D Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter Valid
T44.3X6S Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela Valid
T44.4 Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists Not billable
T44.4X Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists Not billable
T44.4X1 Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional) Not billable
T44.4X1A Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter Valid
T44.4X1D Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter Valid
T44.4X1S Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela Valid
T44.4X2 Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm Not billable
T44.4X2A Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter Valid
T44.4X2D Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter Valid
T44.4X2S Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela Valid
T44.4X3 Poisoning by predominantly alpha-adrenoreceptor agonists, assault Not billable
T44.4X3A Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter Valid
T44.4X3D Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter Valid
T44.4X3S Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela Valid
T44.4X4 Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined Not billable
T44.4X4A Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter Valid
T44.4X4D Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter Valid
T44.4X4S Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela Valid
T44.4X5 Adverse effect of predominantly alpha-adrenoreceptor agonists Not billable
T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter Valid
T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter Valid
T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela Valid
T44.4X6 Underdosing of predominantly alpha-adrenoreceptor agonists Not billable
T44.4X6A Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter Valid
T44.4X6D Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter Valid
T44.4X6S Underdosing of predominantly alpha-adrenoreceptor agonists, sequela Valid
T44.5 Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists Not billable
T44.5X Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists Not billable
T44.5X1 Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional) Not billable
T44.5X1A Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter Valid
T44.5X1D Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter Valid
T44.5X1S Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela Valid
T44.5X2 Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm Not billable
T44.5X2A Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter Valid
T44.5X2D Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter Valid
T44.5X2S Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela Valid
T44.5X3 Poisoning by predominantly beta-adrenoreceptor agonists, assault Not billable
T44.5X3A Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter Valid
T44.5X3D Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter Valid
T44.5X3S Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela Valid
T44.5X4 Poisoning by predominantly beta-adrenoreceptor agonists, undetermined Not billable
T44.5X4A Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter Valid
T44.5X4D Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter Valid
T44.5X4S Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela Valid
T44.5X5 Adverse effect of predominantly beta-adrenoreceptor agonists Not billable
T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter Valid
T44.5X5D Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter Valid
T44.5X5S Adverse effect of predominantly beta-adrenoreceptor agonists, sequela Valid
T44.5X6 Underdosing of predominantly beta-adrenoreceptor agonists Not billable
T44.5X6A Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter Valid
T44.5X6D Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter Valid
T44.5X6S Underdosing of predominantly beta-adrenoreceptor agonists, sequela Valid
T44.6 Poisoning by, adverse effect of and underdosing of alpha-adrenoreceptor antagonists Not billable
Page 70 of 148